Related Experiment Video
Updated: May 4, 2026
Screening Assay for Oxidative Stress in a Feline Astrocyte Cell Line, G355-5
Published on: July 13, 2011
Glia maturation factor deficiency suppresses 1-methyl-4-phenylpyridinium-induced oxidative stress in astrocytes
Mohammad Moshahid Khan1, Duraisamy Kempuraj, Smita Zaheer
1Department of Neurology, University of Iowa, Iowa City, IA, 52242, USA.
Abstract:
Inflammation is closely intertwined with pathogenesis of Parkinson's disease (PD). Increasing evidence suggests that inhibition of glia-mediated inflammation might represent a promising therapeutic target for PD. Glia maturation factor (GMF), an inflammatory protein, predominantly localized in astrocytes is previously isolated, sequenced and cloned in our laboratory. In the present investigation, we demonstrate that GMF-deficiency in astrocytes upregulates the antioxidant status and limit the extent of lipid peroxidation and production of reactive oxygen species (ROS) along with diminished nuclear factor-κB-mediated inflammatory responses in 1-methyl-4-phenylpyridinium (MPP(+))-induced toxicity. Primary astrocytes obtained from wild-type (Wt) and GMF-deficient (GMF-KO) mice were treated with 5, 10, and 20 μM MPP(+) for 24, 48, and 72 h in vitro. Our results show decreased release of ROS and increased level of glutathione in astrocytes obtained from GMF-KO mice when compared to astrocytes derived from Wt mice following MPP(+) treatment. Additionally, we found decreased activity of NF-κB, and reduced levels of proinflammatory tumor necrosis factor- α, interleukin-1β (IL-1β), IL-17, IL-33, and chemokine (C-C motif) ligand 2 (CCL2) in GMF-KO astrocytes when compared to Wt astrocytes. Our overall results suggest that GMF-KO astrocytes are significantly resistant to MPP(+) toxicity when compared to Wt astrocytes.
Insights
Glia maturation factor (GMF) deficiency in astrocytes enhances antioxidant defenses and reduces inflammation, offering a potential therapeutic strategy for Parkinson's disease (PD) by increasing resistance to neurotoxins.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Inflammation plays a critical role in Parkinson's disease (PD) pathogenesis.
- Targeting glia-mediated inflammation presents a promising therapeutic avenue for PD.
- Glia maturation factor (GMF), an inflammatory protein found in astrocytes, is a key focus.
Purpose of the Study:
- To investigate the role of GMF in astrocyte response to neurotoxicity.
- To determine if GMF deficiency impacts antioxidant status and inflammatory responses in astrocytes.
- To evaluate the neuroprotective potential of GMF-deficient astrocytes against MPP(+)-induced toxicity.
Main Methods:
- Primary astrocytes from wild-type (Wt) and GMF-deficient (GMF-KO) mice were utilized.
- Astrocytes were exposed to varying concentrations of 1-methyl-4-phenylpyridinium (MPP(+)) for different durations.
- Key markers of oxidative stress, lipid peroxidation, and inflammatory signaling (NF-κB, cytokines) were measured.
Main Results:
- GMF-KO astrocytes exhibited reduced reactive oxygen species (ROS) release and increased glutathione levels post-MPP(+) treatment compared to Wt astrocytes.
- NF-κB activity was diminished in GMF-KO astrocytes.
- Levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-17, IL-33, CCL2) were significantly lower in GMF-KO astrocytes.
Conclusions:
- GMF deficiency confers significant resistance to MPP(+)-induced toxicity in astrocytes.
- GMF-KO astrocytes demonstrate enhanced antioxidant capacity and attenuated inflammatory responses.
- Modulating GMF in astrocytes may represent a novel therapeutic strategy for Parkinson's disease.
More Related Videos
06:43A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
Published on: February 5, 2018
10:59Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein
Published on: June 6, 2025
